Oncology & Cancer

Subsequent neoplasm risk up for decades in child CA survivors

(HealthDay)—Survivors of childhood cancer are at increased risk for treatment-related subsequent neoplasms (SNs), even after age 40 years, according to a study published online Aug. 10 in the Journal of Clinical Oncology.

Oncology & Cancer

Nanobiotix looks to bring cancer treatment to market

Laurent Levy left the University at Buffalo in 1999 with a dream: transforming his recently completed postdoctoral research on nanomedicine into real-world products for patients battling cancer.

Oncology & Cancer

Mouse model improves understanding of clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue ...

page 2 from 4